Free Trial

Novavax (NVAX) SEC Filings & 10K Form

Novavax logo
$8.70 +0.02 (+0.23%)
(As of 12/20/2024 05:51 PM ET)

Recent Novavax SEC Filings

DateFilerForm TypeView
12/18/2024
4:24 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
4:24 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
11:13 AM
King Rachel K. (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/04/2024
5:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:05 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
3:08 PM
Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
10:21 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:01 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:19 PM
Novavax (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/16/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:08 PM
Dubovsky Filip (Reporting)
Novavax (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/21/2024
3:47 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:06 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
7:04 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:37 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/10/2024
5:16 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
06/20/2024
4:08 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
1:35 PM
Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
Form SC 13G/A
06/06/2024
6:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
8:35 PM
Novavax (Filer)
Form DEFA14A
05/20/2024
1:42 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/20/2024
5:09 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/15/2024
8:15 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
1:39 PM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2024
7:05 AM
Novavax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
3:53 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
4:21 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/07/2024
1:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
05/06/2024
3:43 PM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form DFAN14A
05/06/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form PREC14A
04/29/2024
6:58 AM
Novavax (Filer)
Form DEFA14A
04/29/2024
7:01 AM
Novavax (Filer)
Form ARS
04/29/2024
6:54 AM
Novavax (Filer)
Form DEF 14A
04/15/2024
11:18 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D/A
04/15/2024
5:00 AM
Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
Form SC 13D
03/26/2024
6:00 PM
Casey Mark J (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:00 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:01 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:02 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2024
6:03 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

03/26/2024
5:11 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:45 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
7:46 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:39 PM
Kelly James Patrick (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Novavax (Issuer)
Trizzino John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
8:40 PM
Dubovsky Filip (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:30 PM
Novavax (Issuer)
O'Hara Elaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:07 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
6:30 AM
Novavax (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2024
5:02 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
12:59 PM
MORGAN STANLEY (Filed by)
Novavax (Subject)
Form SC 13G
01/31/2024
7:00 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
4:00 PM
Jacobs John C (Reporting)
Novavax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
7:57 AM
Novavax (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/08/2024
8:25 AM
Novavax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NVAX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners